- Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol2016 | Second Faculty of Medicine
- Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial2017 | Second Faculty of Medicine
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study2009 | First Faculty of Medicine
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study2009 | Second Faculty of Medicine
- IKZF1(plus) Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia2018 | Second Faculty of Medicine
- Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 20022014 | Second Faculty of Medicine
- Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia2010 | Second Faculty of Medicine
- Leukemia surfaceome analysis reveals new disease-associated features2013 | Second Faculty of Medicine
- Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial2016 | Second Faculty of Medicine
- Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia2011 | First Faculty of Medicine
- Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up2018 | Publication without faculty affiliation
- The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia2021 | Second Faculty of Medicine
- Radical surgery and intensive chemotherapy are necessary for successful treatment of osteosarcoma2009 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias2024 | Second Faculty of Medicine
- Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL2023 | Second Faculty of Medicine
- Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study2016 | Second Faculty of Medicine
- Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report2019 | Publication without faculty affiliation